[{"Assets_0_Q2_USD":4393384000.0,"CommonStockSharesOutstanding_0_Q2_shares":179433316.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-79206000.0,"NetIncomeLoss_1_Q2_USD":-37435000.0,"NetIncomeLoss_2_Q2_USD":-93908000.0,"StockholdersEquity_0_Q2_USD":2960954000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":179048000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":178662000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190802"}]